{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T22:17:55Z","timestamp":1792189075036,"version":"4.4.0"},"reference-count":54,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T00:00:00Z","timestamp":1684281600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>\n                      <jats:italic>SOD1<\/jats:italic>\n                      was the first gene associated with both familial and sporadic forms of amyotrophic lateral sclerosis (ALS) and is the second most mutated gene in Caucasian ALS patients. Given their high clinical and molecular heterogeneity, a detailed characterization of\n                      <jats:italic>SOD1<\/jats:italic>\n                      -ALS patients could improve knowledge about the natural history of this disease. Here, the authors aimed to provide a clinical and molecular description of a monocentric cohort of\n                      <jats:italic>SOD1<\/jats:italic>\n                      -ALS patients.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Amyotrophic lateral sclerosis (ALS) patients referring to the neurology unit of our center between 2008 and 2021 were clinically assessed and underwent molecular testing for\n                      <jats:italic>SOD1<\/jats:italic>\n                      . Segregation studies in available family members and\n                      <jats:italic>in silico<\/jats:italic>\n                      analysis were performed to sustain the pathogenicity of the identified\n                      <jats:italic>SOD1<\/jats:italic>\n                      variants.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among the 576 patients in our cohort, we identified 19 individuals harboring a mutation in\n                      <jats:italic>SOD1<\/jats:italic>\n                      (3.3%), including 15 (78.9%) with a familial and four (21.1%) with a sporadic form. The spinal onset of the disease was observed in all patients, and survival was extremely variable, ranging from 8\u2009months to over 30\u2009years. Twelve different\n                      <jats:italic>SOD1<\/jats:italic>\n                      missense variants were identified in our cohort, including one novel mutation (p.Pro67Leu).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>\n                      In the present series, we provided the first description of an Italian monocentric cohort of\n                      <jats:italic>SOD1<\/jats:italic>\n                      -ALS patients, and we expanded the repertoire of\n                      <jats:italic>SOD1<\/jats:italic>\n                      mutations. Our cohort presents several remarkable features, including variable expressivity in the same family, atypical presentation (ataxia, cognitive impairment, and other extra-motor symptoms), and different modes of inheritance of a given mutation in the same family. Given the recent authorization of\n                      <jats:italic>SOD1<\/jats:italic>\n                      -directed antisense oligonucleotide for use in\n                      <jats:italic>SOD1<\/jats:italic>\n                      -ALS patients, we recommend prompt screening for\n                      <jats:italic>SOD1<\/jats:italic>\n                      mutations in novel ALS patients with familiar or sporadic presentations.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fneur.2023.1169689","type":"journal-article","created":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T01:42:53Z","timestamp":1684287773000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":21,"title":["Clinical and molecular features of patients with amyotrophic lateral sclerosis and SOD1 mutations: a monocentric study"],"prefix":"10.3389","volume":"14","author":[{"given":"Delia","family":"Gagliardi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Ripellino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megi","family":"Meneri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Del Bo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Antognozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo Pietro","family":"Comi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Gobbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia","family":"Ratti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Ticozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Silani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dario","family":"Ronchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Corti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,5,17]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/362059a0","article-title":"Mutations in cu\/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis","volume":"362","author":"Rosen","year":"1993","journal-title":"Nature"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1136\/jnnp-2016-315018","article-title":"Genetic epidemiology of amyotrophic lateral sclerosis: a systematic review and meta-analysis","volume":"88","author":"Zou","year":"2017","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1080\/21678421.2019.1606244","article-title":"The project MinE databrowser: bringing large-scale whole-genome sequencing in ALS to researchers and the public","volume":"20","author":"Raa","year":"2019","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s40035-016-0050-8","article-title":"Genotype-phenotype correlations of amyotrophic lateral sclerosis","volume":"5","author":"Li","year":"2016","journal-title":"Transl Neurodegener"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"E2546","DOI":"10.1073\/pnas.1721022115","article-title":"Effects of maturation on the conformational free-energy landscape of SOD1","volume":"115","author":"Culik","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"3108","DOI":"10.1093\/brain\/awac165","article-title":"Altered SOD1 maturation and post-translational modification in amyotrophic lateral sclerosis spinal cord","volume":"145","author":"Trist","year":"2022","journal-title":"Brain"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"336","DOI":"10.3389\/fncel.2015.00336","article-title":"SOD1 misplacing and mitochondrial dysfunction in amyotrophic lateral sclerosis pathogenesis","volume":"9","author":"Tafuri","year":"2015","journal-title":"Front Cell Neurosci"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1126\/science.8209258","article-title":"Motor neuron degeneration in mice that express a human cu, Zn superoxide dismutase mutation","volume":"264","author":"Gurney","year":"1994","journal-title":"Science"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.1093\/brain\/awt097","article-title":"Is SOD1 loss of function involved in amyotrophic lateral sclerosis?","volume":"136","author":"Saccon","year":"2013","journal-title":"Brain"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1006\/nbdi.2002.0508","article-title":"CuZn-superoxide dismutase in D90A heterozygotes from recessive and dominant ALS pedigrees","volume":"10","author":"Jonsson","year":"2002","journal-title":"Neurobiol Dis"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1007\/s12035-014-8724-7","article-title":"Antisense oligonucleotide therapy for the treatment of C9ORF72 ALS\/FTD diseases","volume":"50","author":"Riboldi","year":"2014","journal-title":"Mol Neurobiol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/S1474-4422(13)70061-9","article-title":"An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial amyotrophic lateral sclerosis: a phase 1, randomised, first-in-man study","volume":"12","author":"Miller","year":"2013","journal-title":"Lancet Neurol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1056\/NEJMoa2003715","article-title":"Phase 1-2 trial of antisense oligonucleotide Tofersen for SOD1 ALS","volume":"383","author":"Miller","year":"2020","journal-title":"N Engl J Med"},{"key":"ref14","year":"2022"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1056\/NEJMoa2204705","article-title":"Trial of antisense oligonucleotide Tofersen for SOD1 ALS","volume":"387","author":"Miller","year":"2022","journal-title":"N Engl J Med"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.clinph.2007.09.143","article-title":"Electrodiagnostic criteria for diagnosis of ALS","volume":"119","author":"de Carvalho","year":"2008","journal-title":"Clin Neurophysiol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.ajhg.2016.08.016","article-title":"REVEL: an ensemble method for predicting the pathogenicity of rare missense variants","volume":"99","author":"Ioannidis","year":"2016","journal-title":"Am J Hum Genet"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1212\/wnl.53.2.404","article-title":"A SOD1 gene mutation in a patient with slowly progressing familial ALS","volume":"53","author":"Penco","year":"1999","journal-title":"Neurology"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.jns.2009.05.011","article-title":"The p.E22G mutation in the cu\/Zn superoxide-dismutase gene predicts a long survival time: clinical and genetic characterization of a seven-generation ALS1 Spanish pedigree","volume":"285","author":"Syriani","year":"2009","journal-title":"J Neurol Sci"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.jns.2008.09.030","article-title":"Amyotrophic lateral sclerosis linked to a novel SOD1 mutation with muscle mitochondrial dysfunction","volume":"276","author":"Corti","year":"2009","journal-title":"J Neurol Sci"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"237","DOI":"10.3109\/17482968.2011.627588","article-title":"A novel P66S mutation in exon 3 of the SOD1 gene with early onset and rapid progression","volume":"13","author":"Keckarevi\u0107","year":"2012","journal-title":"Amyotroph Lateral Scler"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1212\/wnl.47.5.1336","article-title":"D90A heterozygosity in the SOD1 gene is associated with familial and apparently sporadic amyotrophic lateral sclerosis","volume":"47","author":"Robberecht","year":"1996","journal-title":"Neurology"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"S43","DOI":"10.1080\/14660820152415735","article-title":"Genetics of ALS in Italian families","volume":"2","author":"Gellera","year":"2001","journal-title":"Amyotroph Lateral Scler Other Motor Neuron Disord"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1212\/wnl.48.1.55","article-title":"Prognosis in familial amyotrophic lateral sclerosis: progression and survival in patients with glu100gly and ala4val mutations in cu,Zn superoxide dismutase","volume":"48","author":"Juneja","year":"1997","journal-title":"Neurology"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"3568","DOI":"10.1093\/hmg\/dds188","article-title":"Mutant superoxide dismutase-1 indistinguishable from wild-type causes ALS","volume":"21","author":"Synofzik","year":"2012","journal-title":"Hum Mol Genet"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"127","DOI":"10.3109\/21678421.2014.966312","article-title":"A novel p.E121G heterozygous missense mutation of SOD1 in an apparently sporadic ALS case with a 14-year course","volume":"16","author":"Canosa","year":"2015","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"131","DOI":"10.3109\/21678421.2014.965179","article-title":"A novel p.E121G SOD1 mutation in slowly progressive form of amyotrophic lateral sclerosis induces cytoplasmic aggregates in cultured motor neurons and reduces cell viability","volume":"16","author":"Dangoumau","year":"2015","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/s0022-510x(01)00625-6","article-title":"ALS with variable phenotypes in a six-generation family caused by leu144phe mutation in the SOD1 gene","volume":"191","author":"Mas\u00e8","year":"2001","journal-title":"J Neurol Sci"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"e645","DOI":"10.1212\/NXG.0000000000000645","article-title":"Homozygous SOD1 variation L144S produces a severe form of amyotrophic lateral sclerosis in an Iranian family","volume":"8","author":"Gagliardi","year":"2022","journal-title":"Neurol Genet"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/0960-8966(95)00007-A","article-title":"Identification of three novel mutations in the gene for CuZn superoxide dismutase in patients with familial amyotrophic lateral sclerosis","volume":"5","author":"Sapp","year":"1995","journal-title":"Neuromuscul Disord"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1126\/science.8351519","article-title":"Amyotrophic lateral Ssclerosis and structural defects in cu,Zn superoxide dismutase","volume":"261","author":"Deng","year":"1993","journal-title":"Science"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"746060","DOI":"10.3389\/fgene.2021.746060","article-title":"SOD1 mutation Spectrum and natural history of ALS patients in a 15-year cohort in southeastern China","volume":"12","author":"Chen","year":"2021","journal-title":"Front Genet"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1017\/s0317167100013329","article-title":"A novel exon 3 mutation (P66S) in the SOD1 gene in familial ALS","volume":"39","author":"Baek","year":"2012","journal-title":"Can J Neurol Sci"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"1017.e17","DOI":"10.1016\/j.neurobiolaging.2011.12.003","article-title":"Screening of the SOD1, FUS, TARDBP, ANG, and OPTN mutations in Korean patients with familial and sporadic ALS","volume":"33","author":"Kwon","year":"2012","journal-title":"Neurobiol Aging"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"44606","DOI":"10.1038\/srep44606","article-title":"Analysis of SOD1 mutations in a Chinese population with amyotrophic lateral sclerosis: a case-control study and literature review","volume":"7","author":"Wei","year":"2017","journal-title":"Sci Rep"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"537","DOI":"10.3390\/genes13030537","article-title":"SOD-1 variants in amyotrophic lateral sclerosis: systematic re-evaluation according to ACMG-AMP guidelines","volume":"13","author":"Ruffo","year":"2022","journal-title":"Genes"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1136\/jmedgenet-2021-107965","article-title":"Role of genetics in amyotrophic lateral sclerosis: a large cohort study in Chinese mainland population","volume":"59","author":"Chen","year":"2022","journal-title":"J Med Genet"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1136\/jmg.2010.077180","article-title":"SOD1, ANG, VAPB, TARDBP, and FUS mutations in familial amyotrophic lateral sclerosis: genotype-phenotype correlations","volume":"47","author":"Millecamps","year":"2010","journal-title":"J Med Genet"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1080\/21678421.2021.1990344","article-title":"Compound heterozygous P67S\/D91A SOD1 mutations in an ALS family with apparently sporadic case","volume":"23","author":"De La Cruz","year":"2021","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1016\/j.nmd.2006.07.004","article-title":"SOD1 gene mutations in Italian patients with sporadic amyotrophic lateral sclerosis (ALS)","volume":"16","author":"Corrado","year":"2006","journal-title":"Neuromuscul Disord"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"220","DOI":"10.3109\/17482968.2010.545951","article-title":"Sporadic motor neuron disease in a familial novel SOD1 mutation: incomplete penetrance or chance association?","volume":"12","author":"Conforti","year":"2011","journal-title":"Amyotroph Lateral Scler"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"568","DOI":"10.3109\/17482961003636874","article-title":"An unusual case of familial ALS and cerebellar ataxia","volume":"11","author":"Yasser","year":"2010","journal-title":"Amyotroph Lateral Scler"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1080\/21678421.2020.1746344","article-title":"A novel p.N66T mutation in exon 3 of the SOD1 gene: report of two families of ALS patients with early cognitive impairment","volume":"21","author":"Martinelli","year":"2020","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1136\/jnnp-2016-313521","article-title":"Defining SOD1 ALS natural history to guide therapeutic clinical trial design","volume":"88","author":"Bali","year":"2017","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/nn.3584","article-title":"State of play in amyotrophic lateral sclerosis genetics","volume":"17","author":"Renton","year":"2014","journal-title":"Nat Neurosci"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"E6807","DOI":"10.3390\/ijms21186807","article-title":"Clinical and molecular landscape of ALS patients with SOD1 mutations: novel pathogenic variants and novel phenotypes. A single ALS center study","volume":"21","author":"Bernard","year":"2020","journal-title":"Int J Mol Sci"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"325.e7","DOI":"10.1016\/j.neurobiolaging.2018.05.009","article-title":"Frequency of C9orf72 hexanucleotide repeat expansion and SOD1 mutations in Portuguese patients with amyotrophic lateral sclerosis","volume":"70","author":"Gromicho","year":"2018","journal-title":"Neurobiol Aging"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1093\/brain\/120.10.1723","article-title":"Phenotypic heterogeneity in motor neuron disease patients with CuZn-superoxide dismutase mutations in Scandinavia","volume":"120","author":"Andersen","year":"1997","journal-title":"Brain"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s12031-010-9480-4","article-title":"Phenotypic heterogeneity in a SOD1 G93D Italian ALS family: an example of human model to study a complex disease","volume":"44","author":"Penco","year":"2011","journal-title":"J Mol Neurosci"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1007\/s00415-009-0078-0","article-title":"SOD1 and cognitive dysfunction in familial amyotrophic lateral sclerosis","volume":"256","author":"Wicks","year":"2009","journal-title":"J Neurol"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"e707","DOI":"10.1212\/WNL.0000000000005002","article-title":"Unraveling ALS due to SOD1 mutation through the combination of brain and cervical cord MRI","volume":"90","author":"Agosta","year":"2018","journal-title":"Neurology"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.4103\/1673-5374.361535","article-title":"The landscape of cognitive impairment in superoxide dismutase 1-amyotrophic lateral sclerosis","volume":"18","author":"Martinelli","year":"2023","journal-title":"Neural Regen Res"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1038\/D41573-021-00181-W","article-title":"ALS antisense drug falters in phase III","volume":"20","author":"Mullard","year":"2021","journal-title":"Nat Rev Drug Discov"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2023.1169689\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T01:42:55Z","timestamp":1684287775000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2023.1169689\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,17]]},"references-count":54,"alternative-id":["10.3389\/fneur.2023.1169689"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2023.1169689","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,17]]},"article-number":"1169689"}}